Branka Petričević
About
In The Last Decade
Branka Petričević
12 papers receiving 292 citations
Peers
Comparison fields: 5 of 52
- Immunology 166
- Oncology 147
- Radiology, Nuclear Medicine and Imaging 88
- Molecular Biology 76
- Cancer Research 44
Countries citing papers authored by Branka Petričević
This map shows the geographic impact of Branka Petričević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branka Petričević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branka Petričević more than expected).
Fields of papers citing papers by Branka Petričević
This network shows the impact of papers produced by Branka Petričević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branka Petričević. The network helps show where Branka Petričević may publish in the future.
Co-authorship network of co-authors of Branka Petričević
This figure shows the co-authorship network connecting the top 25 collaborators of Branka Petričević. A scholar is included among the top collaborators of Branka Petričević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Branka Petričević. Branka Petričević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 3 | |
| 3 | Treatment Resistant de novo Epidermal Growth Factor Receptor (EGFR)-mutated Small Cell Lung Cancer | 2 |
| 4 | 0 | |
| 5 | 148 | |
| 6 | 5 | |
| 7 | 26 | |
| 8 | 23 | |
| 9 | [Consensus guidelines for diagnosis, treatment and follow-up of patients with gastrointestinal stromal tumors]. | 1 |
| 10 | 45 | |
| 11 | 17 | |
| 12 | Estrogen and progesterone receptor status in primary breast cancer--a study of 11,273 patients from the year 1990 to 2002. | 6 |
| 13 | [Gastrointestinal stromal tumors (GIST)--a paradigm of successful targeted therapy of solid tumors]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.